Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy.

@article{Birbeck2012EvidencebasedGA,
  title={Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy.},
  author={Gretchen Lano Birbeck and J. A. Photographer French and Emilio Perucca and David M. Simpson and Henry S. Fraimow and Jomy M. George and Jason F. Okulicz and David B Clifford and Houda Hachad and Ren{\'e} H. Levy},
  journal={Neurology},
  year={2012},
  volume={78 2},
  pages={
          139-45
        }
}
OBJECTIVE To develop guidelines for selection of antiepileptic drugs (AEDs) among people with HIV/AIDS. METHODS The literature was systematically reviewed to assess the global burden of relevant comorbid entities, to determine the number of patients who potentially utilize AEDs and antiretroviral agents (ARVs), and to address AED-ARV interactions. RESULTS AND RECOMMENDATIONS AED-ARV administration may be indicated in up to 55% of people taking ARVs. Patients receiving phenytoin may require… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 26 CITATIONS

Seizures in HIV: The case for special consideration

  • Epilepsy & Behavior Case Reports
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 37 REFERENCES

The effect of raltegravir on the glucuronidation of lamotrigine

M van Luin, A Colbers, CP Verwey-van Wissen
  • J Clin Pharmacol
  • 2009

The effect of atazanavir and atazanavir/ritonavir on UDPglucuronosyltransferase using lamotrigine as a phenotypic probe

DM Burger, A Huisman, N Van Ewijk
  • Clin Pharmacol Ther 2008;84:698–703
  • 2008

Clinically significant drug interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected subject.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2007

Similar Papers

Loading similar papers…